

As existing antimicrobial agents decline in effectiveness, infections will be more difficult and expensive to treat and epidemics harder to control. The World Health Organization (WHO) projects the terrifying prospect of 10 million AMR-related deaths per year globally by 2050. In the U.S., the Centers for Disease Control and Prevention (CDC) estimates that more than 2.8 million antimicrobial resistant infections occur each year and cause more than 35,000 deaths.
Key Causes of AMR:
- Over-prescription of antimicrobials.
- Shortened courses or incomplete compliance with antimicrobial treatment.
- Antimicrobial overuse in livestock and fish farming.
- Poor infection control in health care settings.
- Poor hygiene and sanitation.
- Limited discovery of new antimicrobials.
AMR genes are incredibly promiscuous, circulating through humans, animals, plants and the environment. Implementing a One Health approach is key to combating the spread of resistance.
Featured Content
Mechanisms of Resistance
AMR Policy and Advocacy Initiatives
Policy to Combat AMR
抖阴热门 recommends steps for policymakers that prioritize science and the roles of microbiologists to combat AMR.
The 抖阴热门 actively works with federal and global partners to advance legislation to combat AMR and other health threats.
- 抖阴热门 Commends Quadripartite AMR Plan Draft.
- 抖阴热门, IDSA, SHEA & PIDS Request PACCARB Meet Immediately.
- 抖阴热门 Submits Comments to PACCARB on AMR One Health Approach.
- 抖阴热门 Urges Increased Support of Research at USDA.
- 抖阴热门 Requests Increased FY26 Funding for NIH and CDC.
- 抖阴热门 Policy Recommendations to Combat Antimicrobial Resistance.
- 抖阴热门 Recommends Priorities for U.S. Delegation to UN General Assembly.
- 抖阴热门 Applauds Introduction of FORWARD Act.
- 抖阴热门 Recommendations for Cures Legislation Next Steps.
Downloadable Factsheets
Developing Solutions
Hear From Experts
Diagnosing Tuberculosis in Developing Countries With Aureliana Chambal Chilengue
EiC invites trainees, who will be the next generation of outstanding researchers in the field of AMR, to discuss pathways to work on antimicrobial resistance.
Rethinking Antimicrobial Resistance With Amy Mathers, M.D., D(ABMM)
Engage in Discussions About Antimicrobial Agents and Resistance
Join experts in antimicrobial agents and resistance (AAR) for a discussion on the latest issues impacting the field. Each quarter, panelists gather for a 1-hour virtual panel discussion on a predetermined topic. This quarterly panel is free for 抖阴热门 members. Join or renew your membership today!